Citadel Advisors’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-62,818
Closed -$184K 14214
2022
Q2
$184K Sell
62,818
-58,631
-48% -$245K ﹤0.01% 10798
2022
Q1
$717K Buy
121,449
+12,877
+12% +$80.9K ﹤0.01% 8510
2021
Q4
$774K Buy
108,572
+48,071
+79% +$369K ﹤0.01% 8571
2021
Q3
$501K Sell
60,501
-66,691
-52% -$620K ﹤0.01% 9861
2021
Q2
$1.31M Buy
127,192
+102,680
+419% +$1.43M ﹤0.01% 7645
2021
Q1
$352K Buy
24,512
+12,037
+96% +$155K ﹤0.01% 10478
2020
Q4
$118K Buy
+12,475
New +$95.4K ﹤0.01% 10116
2019
Q2
Sell
-20,386
Closed -$75K 10110
2019
Q1
$75K Buy
+20,386
New +$74.1K ﹤0.01% 8657
2015
Q4
Sell
-3,843
Closed -$34K 9375
2015
Q3
$34K Buy
3,843
+2,623
+215% +$19K ﹤0.01% 7841
2015
Q2
$8K Buy
+1,220
New +$7.64K ﹤0.01% 8467
2014
Q2
Sell
-10,969
Closed -$50K 8427
2014
Q1
$50K Buy
+10,969
New +$51.7K ﹤0.01% 6784

Citadel Advisors's SMED Position: Q3 2022 in Review

Citadel Advisors sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 62,818 shares — an estimated $184K sold.

Citadel Advisors first reported a position in SMED in Q1 2014 and held it in 11 quarters. The position peaked at $1.31M in Q2 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

  • Citadel Advisors reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 62,818 Sharps Compliance Corp shares in Q3 2022, an estimated $184K.
  • Citadel Advisors first reported a position in Sharps Compliance Corp in Q1 2014 and held it in 11 quarters.
  • Citadel Advisors's Sharps Compliance Corp position peaked at $1.31M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.